David Piwnica‐Worms

26.0k citations

282 papers · 19.5k indexed · 4 hit papers · h-index 71

Molecular Biology top 0.5%
Oncology top 0.2%
Immunology top 0.5%
Radiology, Nuclear Medicine and Imaging top 0.2%
Cancer Research top 0.5%

Co-authors: Julie L. Prior Seth T. Gammon James F. Kronauge Mark L. Chiu Gary D. Luker Shimon Gross Vijay Sharma Helen Piwnica‐Worms
Topics: Radiopharmaceutical Chemistry and Applications (32 papers)Drug Transport and Resistance Mechanisms (30 papers)bioluminescence and chemiluminescence research (24 papers)
Cited by: Oncology Cancer Research Immunology
Journals: Nature Chemical Reviews Proceedings of the National Academy of Sciences
Partner nations: United States Ireland Italy

In The Last Decade

David Piwnica‐Worms

279 papers receiving 19.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glypican-1 identifies cancer exosomes and detects early pancreatic cancer

2015 2.2k citations Seth T. Gammon, David Piwnica‐Worms et al. profile →
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses

2012 759 citations Lynne Collins, David Piwnica‐Worms et al. Cancer Research profile →
Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor Clearance

2007 726 citations Xuefang Cao, Sheng F. Cai et al. profile →
CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer

2004 586 citations Joel R. Garbow, Julie L. Prior et al. Cancer Research profile →

Peers

Countries citing papers authored by David Piwnica‐Worms

Since Specialization

Citations

This map shows the geographic impact of David Piwnica‐Worms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Piwnica‐Worms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Piwnica‐Worms more than expected).

Fields of papers citing papers by David Piwnica‐Worms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Piwnica‐Worms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Piwnica‐Worms. The network helps show where David Piwnica‐Worms may publish in the future.

Co-authorship network of co-authors of David Piwnica‐Worms

This figure shows the co-authorship network connecting the top 25 collaborators of David Piwnica‐Worms. A scholar is included among the top collaborators of David Piwnica‐Worms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Piwnica‐Worms. David Piwnica‐Worms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hyperpolarized [1- ¹³ C]pyruvate-to-[1- ¹³ C]lactate conversion is rate-limited by monocarboxylate transporter-1 in the plasma membrane 2020 ·Proceedings of the National Academy of Sciences ·(unknown),Seth T. Gammon,Niki M. Zacharias,Tracy Liu,Travis C. Salzillo,Yuanxin Xi,Jing Wang,Pratip K. Bhattacharya,David Piwnica‐Worms	50
2	Analysis of RAS protein interactions in living cells reveals a mechanism for pan-RAS depletion by membrane-targeted RAS binders 2020 ·Proceedings of the National Academy of Sciences ·(unknown),Nikki K. Lytle,Seth T. Gammon,(unknown),Tikvah K. Hayes,Margie N. Sutton,Robert C. Bast,Channing J. Der,David Piwnica‐Worms,Frank McCormick,Geoffrey M. Wahl	12
3	Assessing Metabolic Intervention with a Glutaminase Inhibitor in Real-Time by Hyperpolarized Magnetic Resonance in Acute Myeloid Leukemia 2019 ·Molecular Cancer Therapeutics ·Niki M. Zacharias,Natalia Baran,Sriram S. Shanmugavelandy,Jae-Hyuk Lee,(unknown),Prasanta Dutta,Steven W. Millward,Tianyu Cai,Christopher G. Wood,David Piwnica‐Worms,Marina Konopleva,Pratip K. Bhattacharya	22
4	Nucleoside Diphosphate Kinase-3 ( NME3 ) Enhances TLR5-Induced NF κ B Activation 2018 ·Molecular Cancer Research ·Kelly Flentie,Caleb González,(unknown),Yue Wang,Hongtu Zhu,Jayne Marasa,David Piwnica‐Worms	17
5	A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models 2018 ·Clinical Cancer Research ·Pascal O. Zinn,Sanjay K. Singh,Aikaterini Kotrotsou,Islam Hassan,Ginu Thomas,Markus M. Luedi,Ahmed Elakkad,Nabil Elshafeey,(unknown),(unknown),Joy Gumin,Gregory N. Fuller,John de Groot,Veera Baladandayuthapani,Erik P. Sulman,Ashok J. Kumar,Raymond Sawaya,Frederick F. Lang,David Piwnica‐Worms,Rivka R. Colen	80
6	DAPK3 Suppresses Acini Morphogenesis and Is Required for Mouse Development 2014 ·Molecular Cancer Research ·(unknown),Lynn S. White,David Piwnica‐Worms	10
7	A High-Throughput Fluorimetric Assay for 2-Hydroxyglutarate Identifies Zaprinast as a Glutaminase Inhibitor 2014 ·Cancer Discovery ·Adnan Elhammali,Joseph E. Ippolito,Lynne Collins,Jan R. Crowley,Jayne Marasa,David Piwnica‐Worms	66
8	A Bioluminescent Transposon Reporter-Trap Identifies Tumor-Specific Microenvironment-Induced Promoters in Salmonella for Conditional Bacterial-Based Tumor Therapy 2012 ·Cancer Discovery ·Kelly Flentie,(unknown),Seth T. Gammon,Deborah V. Novack,(unknown),David Piwnica‐Worms	67
9	Antagonism of Inhibitor of Apoptosis Proteins Increases Bone Metastasis via Unexpected Osteoclast Activation 2012 ·Cancer Discovery ·Chang Yang,Jennifer L. Davis,Rong Zeng,(unknown),Xinming Su,Lynne Collins,Suwanna Vangveravong,Robert H. Mach,David Piwnica‐Worms,Katherine N. Weilbaecher,Roberta Faccio,Deborah V. Novack	34
10	Hedgehog Signaling Inhibition Blocks Growth of Resistant Tumors through Effects on Tumor Microenvironment 2011 ·Cancer Research ·Emanuela Heller,Michelle A. Hurchla,Jingyu Xiang,Xinming Su,(unknown),Jochen G. Schneider,(unknown),Marcos Vidal,Leah Goldberg,Hongju Deng,(unknown),Julie L. Prior,David Piwnica‐Worms,Fanxin Long,Ross Cagan,Katherine N. Weilbaecher	66
11	A Pharmacologic Inhibitor of the Protease Taspase1 Effectively Inhibits Breast and Brain Tumor Growth 2011 ·Cancer Research ·David Y. Chen,(unknown),Brian A. Van Tine,Adam C. Searleman,Todd D. Westergard,Han Liu,Ho-Chou Tu,Shugaku Takeda,Yiyu Dong,David Piwnica‐Worms,Kyoung Joon Oh,Stanley J. Korsmeyer,Ann Hermone,(unknown),Robert H. Shoemaker,Emily H. Cheng,James J. Hsieh	35
12	Suppression of G-protein–Coupled Receptor Kinase 3 Expression Is a Feature of Classical GBM That Is Required for Maximal Growth 2011 ·Molecular Cancer Research ·B. Mark Woerner,Jingqin Luo,(unknown),Erin Jackson,Sonika Dahiya,Paul S. Mischel,Jeffrey Benovic,David Piwnica‐Worms,Joshua B. Rubin	33
13	Cyclic AMP Suppression Is Sufficient to Induce Gliomagenesis in a Mouse Model of Neurofibromatosis-1 2010 ·Cancer Research ·Nicole M. Warrington,Scott M. Gianino,Erin Jackson,Patricia Goldhoff,Joel R. Garbow,David Piwnica‐Worms,David H. Gutmann,Joshua B. Rubin	87
14	The Neurofibromatosis Type 1 Tumor Suppressor Controls Cell Growth by Regulating Signal Transducer and Activator of Transcription-3 Activity In vitro and In vivo 2010 ·Cancer Research ·Sutapa Banerjee,(unknown),Scott M. Gianino,Scott E. Harpstrite,Fausto J. Rodríguez,Robert G. Tuskan,Karlyne M. Reilly,David Piwnica‐Worms,David H. Gutmann	49
15	CD47 Regulates Bone Mass and Tumor Metastasis to Bone 2009 ·Cancer Research ·Özge Uluçkan,(unknown),Hongju Deng,Wei Zou,Julie L. Prior,David Piwnica‐Worms,William A. Frazier,Katherine N. Weilbaecher	67
16	Vascular Endothelial Growth Factor Receptor-1 Is Synthetic Lethal to Aberrant β-Catenin Activation in Colon Cancer 2009 ·Clinical Cancer Research ·Snehal Naik,Robin S. Dothager,Jayne Marasa,(unknown),David Piwnica‐Worms	58
17	Interleukin 12 Stimulates IFN-γ–Mediated Inhibition of Tumor-Induced Regulatory T-Cell Proliferation and Enhances Tumor Clearance 2009 ·Cancer Research ·Xuefang Cao,(unknown),Lynne Collins,Sheng F. Cai,(unknown),Jacqueline E. Payton,Michael Walter,David Piwnica‐Worms,Robert D. Schreiber,Timothy J. Ley	70
18	Senescent Stromal-Derived Osteopontin Promotes Preneoplastic Cell Growth 2009 ·Cancer Research ·Ermira Pazolli,Xianmin Luo,(unknown),Kelly Carbery,Jun-Jae Chung,Julie L. Prior,Jason M. Doherty,Shadmehr Demehri,(unknown),David Piwnica‐Worms,Sheila A. Stewart	122
19	Blocking CXCR4-Mediated Cyclic AMP Suppression Inhibits Brain Tumor Growth In vivo 2007 ·Cancer Research ·Lihua Yang,Erin Jackson,B. Mark Woerner,Arie Perry,David Piwnica‐Worms,Joshua B. Rubin	115
20	Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancers 2006 ·Proceedings of the National Academy of Sciences ·Joseph E. Ippolito,Matthew E. Merritt,Fredrik Bäckhed,Krista L. Moulder,Steven Mennerick,Jill K. Manchester,Seth T. Gammon,David Piwnica‐Worms,Jeffrey I. Gordon	33

About David Piwnica‐Worms

David Piwnica‐Worms is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Biophysics, having authored 282 papers that have together received 19.5k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (32 papers), Drug Transport and Resistance Mechanisms (30 papers) and bioluminescence and chemiluminescence research (24 papers). The work is most often cited by research in Oncology (5.8k citations), Cancer Research (2.7k citations) and Immunology (3.3k citations). David Piwnica‐Worms has collaborated with scholars based in United States, Ireland and Italy. Frequent co-authors include Julie L. Prior, Seth T. Gammon, James F. Kronauge, Mark L. Chiu, Gary D. Luker, Shimon Gross, Vijay Sharma, Helen Piwnica‐Worms, Lynne Collins and Joel R. Garbow. Their work appears in journals such as Nature, Chemical Reviews and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact